NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery. - Test2 - elhamkhani - TriplyDB

NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.

NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.

http://www.wikidata.org/entity/Q30493643

about

Anti-HIV-1 nanotherapeutics: promises and challenges for the future Nanoscale drug delivery systems and the blood-brain barrier Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.Cell delivery of therapeutic nanoparticles Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis Design strategies and applications of circulating cell-mediated drug delivery systems Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy Progress in antiretroviral drug delivery using nanotechnology In vitro suppression of oral squamous cell carcinoma growth by ultrasound-mediated delivery of curcumin microemulsions Pharmacokinetics, biodistribution, and toxicity of folic acid-coated antiretroviral nanoformulations.Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.Endosomal trafficking of nanoformulated antiretroviral therapy facilitates drug particle carriage and HIV clearance.Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in mice Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticles.Registered bioimaging of nanomaterials for diagnostic and therapeutic monitoring.Methods development for blood borne macrophage carriage of nanoformulated antiretroviral drugs.Cell-mediated drug delivery.Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages.Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations.Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages Pulsed stable isotope labeling of amino acids in cell culture uncovers the dynamic interactions between HIV-1 and the monocyte-derived macrophage.Type and composition of surfactants mediating gene transfection of polyethylenimine-coated liposomes.Efficacy of Tat-conjugated ritonavir-loaded nanoparticles in reducing HIV-1 replication in monocyte-derived macrophages and cytocompatibility with macrophages and human neurons Prolonged-acting, multi-targeting gallium nanoparticles potently inhibit growth of both HIV and mycobacteria in co-infected human macrophages.Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cells.Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS.Comparative manufacture and cell-based delivery of antiretroviral nanoformulations.Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells.Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeutics.Long-acting slow effective release antiretroviral therapy.Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages.Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1-infected human peripheral blood lymphocyte-reconstituted mice.Functional proteome of macrophage carried nanoformulated antiretroviral therapy demonstrates enhanced particle carrying capacity Drug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatment.Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections

P2860

Q26828464-C5FC5586-07A8-41D1-90D4-AF874CC6FE4D Q27026978-1098B18F-9C00-48F9-8A27-96388F5CAC07 Q28082016-5454E325-5353-4F19-9C3A-CC6680D90119 Q28385606-E5C659AD-E8E6-45BC-8B26-448C25E2413B Q28486428-E98AAF28-157E-41E6-ADDA-3A28A093DE19 Q28547179-C917D84B-6350-4414-9FC6-206F2E2E04D2 Q28551873-3D5E45CD-ADFD-4E59-A458-78F50479C0BE Q30395011-9A93BDF7-6ACB-4D60-9A8F-A92829A809F1 Q30469832-43BC3712-1E64-43D2-B475-3FDD92587B0C Q30603781-386CA6AC-FB78-4CC7-9341-0127A1C3D4A7 Q33614467-1E009198-28FD-4020-B702-D088538834E9 Q33625213-D72BA87F-CB3D-462A-A9A0-4F27C8E20787 Q33631069-4F6A8541-ED71-4C99-91A3-D8144D22FE31 Q34059457-830C4B81-9D64-4DA2-9743-3B21CA2F0F72 Q34138487-D71C8F25-6F6A-4804-9547-FFCCB4F029AD Q34512904-A726D69C-8694-401E-B39A-010DB2E29E01 Q34566992-507CBEA1-8FFD-4D78-A85A-BEDFBB5E51F8 Q34639915-C7BE18DD-B824-4156-A58F-64CECB8F438A Q34639923-4F099306-895F-46B3-93F6-26FDAE965A48 Q34709440-E3C5DCB8-F8E3-45A0-AFE5-FF6D7C32E67B Q34728884-DB45CA59-A9AE-4A32-B373-AA86D59A605D Q34745586-9914D18F-A76F-493F-9F81-ED42476DCAED Q34797004-E035889E-BC5B-4C9F-A4DF-2E48F36EB97D Q35016131-DFECA74A-3F8F-4296-A91E-ED6E92D443DA Q35025824-23006BD8-CD2E-4AB8-B108-09C765F65B5A Q35071617-4BF32BDC-BD08-43DD-9550-CD4F938AD076 Q35145361-68CE48F4-273D-475A-80D9-8A421EB59A2B Q35153311-8A093CC9-41A2-44EC-846A-BD5D35494C9F Q35194750-A3946736-B87E-4C65-8487-947BABFE1494 Q35606068-95BA6B38-DEDA-41BA-A893-F2CE7C65691A Q35677168-013B8916-FCC8-45C2-B880-58B56649AD7E Q35979166-6FE37577-91EF-4653-B03C-8532DCA83781 Q36107193-54190A56-3A90-48F8-9628-08035E6231E0 Q36262152-60B1285E-79F5-458D-92A5-78A8D5388847 Q36381046-4BA33724-76BA-409E-B6DA-413194A323C5 Q36603756-203DFD33-5F64-4FBC-AA99-B2725DBB9221 Q36875347-FF1ABA9D-A3D8-4CF5-AF6C-8692B30E9F92 Q36934918-B54515A0-9DA9-47EC-8F0C-D3593598A700 Q36969787-F99CBDDC-8D85-4AED-9A05-03715110DFE4 Q37188867-29EFF943-E5AF-4503-8598-C5AD33A4D46D

P2860

NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.

http://www.wikidata.org/entity/Q30493643

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

NanoART synthesis, characteriz ...... cyte-macrophage drug delivery.

@ast

NanoART synthesis, characteriz ...... cyte-macrophage drug delivery.

@en

type

label

NanoART synthesis, characteriz ...... cyte-macrophage drug delivery.

@ast

NanoART synthesis, characteriz ...... cyte-macrophage drug delivery.

@en

prefLabel

NanoART synthesis, characteriz ...... cyte-macrophage drug delivery.

@ast

NanoART synthesis, characteriz ...... cyte-macrophage drug delivery.

@en

P1433

Q30493643-71267C8A-A122-4B34-9111-B2A7548E0E35

P1476

Q30493643-DFEE1137-B158-4688-AD50-C313F648B611

P2093

Q30493643-0497FAF9-6CF8-48C3-88C7-EEF6472CBF33

Q30493643-1512AF0C-C588-4F76-96B7-F03DCAB65F30

Q30493643-1B671F7C-063B-4D36-A5FF-19A8C82459E0

Q30493643-294A7F58-E48B-4C50-979F-50D522EF2607

Q30493643-2C8CE072-3EB1-49E3-A7CE-7E1EC2740F08

Q30493643-3FD38A2B-73C7-4503-98D4-C036159581A3

Q30493643-47C7E4EE-C2F4-42C0-81AF-E477130AC9DE

Q30493643-6AC23FBE-E57A-4E1D-BAE1-AE726316F6A1

Q30493643-7C2944DB-7892-4159-B512-0AF2962325A9

Q30493643-868B0E78-E368-4A25-AB2F-F9C2E56B68D3

P2860

Q30493643-010A5C3E-D5E9-4D4F-A707-C398583E2716

Q30493643-013D2065-0F05-49CF-93F4-AA7F71D03C56

Q30493643-09FC51E0-2247-4B9A-A8A7-2B4B0DF19D47

Q30493643-150BE333-A131-45C3-96B9-02B2FC076EAF

Q30493643-1B0D13FE-8C52-4BCE-9F2D-2081DB868AC9

Q30493643-20A9B280-599C-42EF-851C-9C4AD6BF7FB8

Q30493643-251D6549-EFB4-4805-8263-14E9DA810E97

Q30493643-3B6FD656-5042-40DB-82E6-A2BA7026E9FD

Q30493643-3D2B803C-258A-4E22-8CB6-2D4D8D5416E2

Q30493643-41068103-4278-4A09-A4F0-6683144D641C

P304

Q30493643-8F1CBD36-CD28-46B2-A4C8-248E6AC12E18

P31

Q30493643-0C5157AB-2C67-4D93-B5DA-E6854DDB4120

P356

Q30493643-8490FCC7-AA01-4441-9AF2-6836013FDEDE

P433

Q30493643-F1F77169-FE58-422B-B731-20F3F01E8C5C

P478

Q30493643-F2CA8C75-E4D9-49FB-9F66-92F4FCF17C53

P577

Q30493643-E18EDD1F-2CD6-470D-84B0-43586C9E0460

P5875

Q30493643-B6F0FA9A-5907-416F-BE5E-839E07E21E24

P698

Q30493643-1C3110E7-A13D-48BB-AA8A-AB2F009AEEE1

P921

Q30493643-006BFF09-9178-4E73-98B3-5B5871839CFB

Q30493643-9BF505F8-AC62-487E-B89F-6079CEDAE4C3

P932

Q30493643-632C062E-5420-4B18-8ECC-CC358A4271A8

P356

P1433

P1476

NanoART synthesis, characteriz ...... cyte-macrophage drug delivery.

@en

P2093

Ari S Nowacek

http://www.w3.org/2001/XMLSchema#string

Barrett Rabinow

http://www.w3.org/2001/XMLSchema#string

Georgette Kanmogne

http://www.w3.org/2001/XMLSchema#string

Howard E Gendelman

http://www.w3.org/2001/XMLSchema#string

Huanyu Dou

http://www.w3.org/2001/XMLSchema#string

Jane Werling

http://www.w3.org/2001/XMLSchema#string

Joellyn McMillan

http://www.w3.org/2001/XMLSchema#string

Mahesh Chaubal

http://www.w3.org/2001/XMLSchema#string

Michel Kanmogne

http://www.w3.org/2001/XMLSchema#string

R Lee Mosley

http://www.w3.org/2001/XMLSchema#string

P2860

Facilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticles

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery.

Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment.

Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Cross-linked polymeric nanogel formulations of 5'-triphosphates of nucleoside analogues: role of the cellular membrane in drug release.

Intramuscular preparations of antipsychotics: uses and relevance in clinical practice.

Nanosuspensions in drug delivery.

Antiretroviral therapy in the developing world.

Antiretroviral compounds: mechanisms underlying failure of HAART to eradicate HIV-1.

Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes

P304

903-917

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NNM.09.71

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40445301

http://www.w3.org/2001/XMLSchema#string

P698

19958227

http://www.w3.org/2001/XMLSchema#string

P921

P932

2837804

http://www.w3.org/2001/XMLSchema#string